About Orange Biomed

Our Innovation

It’s not about improving the current technology. It’s about disrupting the old-fashioned IVD method utilized for the last few decades.

We are setting a new standard with single-cell analysis using microfluidic technology.

U.S. Patents Registered
1
OBM rapid A1c, U.S. Patents Registered
Global Patents
1
OBM rapid A1c, 11 Global Patents
The patent for the OBM Rapid A1c Test has been registered in Japan.
The patent for the OBM Rapid A1c Test has been registered in China
The patent for the OBM Rapid A1c Test has been registered all over the world
The patent for the OBM Rapid A1c Test has been registered all over the world

Patents

Recently Registered/Filed

Certifications

​Our Story

In 2019, our two co-presidents met at Duke University, one researching biomedical engineering at Duke Hospital and the other studying healthcare management at Duke Business School.

The pandemic took over the U.S. in 2020. Our co-presidents worked to identify the unmet needs of patients having difficulty visiting a doctor to manage their diabetes due to isolation. This sparked the idea of a new technology and company.

In 2021, Orange Biomed was created to solve unmet diabetes-focused healthcare needs. How? By bringing state-of-the-art POC technology into patients’ homes. Globally, 537 million people have diabetes. Monitoring HbA1C regularly is essential as it predicts a risk of developing life-threatening diabetic complications.

In 2022, Orange Biomed successfully developed a prototype of a portable A1C meter. OBM at-home A1C device is an accessible and affordable care option for better diabetes management.

The home-based medical device fills the significant gap between hospitals and patients’ homes by cutting healthcare costs and providing a better quality of life to people with diabetes.

In 2023 and beyond, Orange Biomed aims for OBM rapid A1c to become a game-changer in patient-oriented healthcare. OBM rapid A1c offers a user-centered design integrated with state-of-the-art technology, providing healthcare solutions for diabetes management.

Our Mission

Orange Biomed’s mission is to bring happiness to the daily lives of those with diabetes. By seamlessly integrating pioneering technology into point-of-care devices, we make healthcare more accessible and affordable for everyone.

Orange Biomed Core Values, Brightness

Brightness

We aim for smart, intelligent, and positive leadership.

Our Core Values

Orange Biomed Core Values, Brightness

Contribution

Our goal is to support our family, friends, community, society, and humanity.

We are dedicated to creating life-saving products.

Orange Biomed Core Values, Brightness

Ownership

We take initiative and hold ourselves accountable.

Orange Biomed Core Values, Brightness

Expedition

We are committed to continuous learning and advancing new technologies, constantly striving to expand our knowledge and global presence.

Orange Biomed Core Values, Brightness

Openness

We actively listen to each other’s feedback, turn ideas into reality, and collaborate to find solutions that meet your needs.

Check Out Our 2023 CSR Initiatives

Investors & Partners

Digital healthcare patner is patner of orange Biomed
RootN Global Investors, partner and Investor of Orange Biomed
RootN Global Investors, partner and Investor of Orange Biomed
industrial bank of Korea, Partner and Investor of Orange Biomed